Latest News for Koninklijke Philips Stock (OTC:RYLPF)

Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Around 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products.

News

Health Care

General

RYLPF

The FDA handed down its Class I label, the most severe recall classification, for Koninkl

FDA Gives &#39;Most Severe&#39; Class I Label To Philips&#39; Recall Of Faulty Ventilators, Sleep Apnea Machines

The Dutch medical equipment firm Koninklijke Philips NV (OTC: RYLPF) has recalled several of its sleep apnea and respiratory care devices due to potential health risks.

Philips Recalls Ventilators And Sleep Apnea Devices Due To Possible Health Risks

Intraday Update

Markets

Movers

Trading Ideas

ACGLO

ACGLP

ACOPF

ACRL

AHNR

AKRO

ALMFF

AMAT

AMYZF

ANSS

APHD

ARCAY

ARCT

ARNGF

ASMIY

ASML

ASMLF

AUDC

BALMF

BGAVF

BHPBF

BKRRF

BPYPP

BYND

CAGDF

CHMA

CHOLF

CKDXY

CMPGY

CNMF

CNNB

CPRT

CRVL

CRWD

CVAS

CZMWY

DCGD

DISH

DRGDF

DYFSF

New Oriental Education & Technology Group

EFIN

ENPH

ESGRO

ESGRP

FALC

FRRVY

FTMNF

GKPRF

GNBT

GNCGF

GNRC

GNTX

HCHDF

HGKGY

IBERIABANK Corporation - Depositary Shares Representing Series B Fixed to Floating

IBKCP

ICGUF

IEHC

INGIY

IPHI

ISCB

ISDAY

ISVLF

JYNT

KDKN

KELYA

KGTFY

KLAC

KNTNF

KRYS

KTOS

LMEFF

LPLA

LRAD

LRCX

LSYN

LZAGF

Stocks that Broke 52-Week Highs Tuesday

ROYAL PHILLIPS NV ORD by Koninklijke Philips N.V

Koninklijke Philips NV

Intel Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) stock fell after reporting a first-quarter (Q1) revenue miss and weak <a href="https://www.benzinga.com/quote/INTC/guidance">Q2 EPS guidance</a>.
The company&#8217;s quarterly earnings of 18 cents per share beat the consensus estimate by 28.57%. However, sales of $12.72 billion missed estimates by 0.44%.
Related: <a href="https://www.benzinga.com/news/earnings/24/04/38444720/intel-shares-fall-on-q1-revenue-miss-weak-q2-eps-guidance">Intel Shares Fall On Q1 Revenue Miss, Weak Q2 EPS Guidance</a>
CEO Pat Gelsinger remains confident in company&#8217;s future, proclaiming &#8220;Intel is back.&#8221;
Here's what analysts have to say about the earnings report.
<ul>
<li>JPMorgan Chase analyst Harlan Sur reiterated Underweight on Intel stock, reducing the price target from $37 to $35 a share.</li>
<li>Goldman Sachs analyst Toshiya Hari maintains his Sell rating on the stock, reducing the price target from $39 to $34.</li>
<li>Oppenheimer analyst Rick Schafer maintained his Perform rating on the stock without stating a price target.</li>
<li>Needham analyst N. Quinn Bolton, CFA reiterated Hold with no price target on the stock.</li>
<li>Wedbush analyst Matt Bryson rates the stock Neutral with his 12-month price target on the stock down from $40 to $32.50 a share.</li>
<li>BofA Securities analyst Vivek Arya reiterated his Neutral rating on the stock, while lowering price target from $44 to $40.</li>
<li>Mizuho Securities analyst Vijay Rakesh rates the stock a Buy with price target lowered from $55 to $45 a share.</li>
</ul>
Also Read: <a href="https://www.benzinga.com/news/24/04/38447614/intel-ceo-said-foundry-business-will-see-sequential-improvement-in-every-quarter-till-2030-conf-call">Intel CEO Said Foundry Business Will See Sequential Improvement In Every Quarter Till 2030- Conf Call</a>
JPMorgan: According to Sur, Intel&#8217;s guidance suggests a slow recovery for PC and data center segments, requiring a strong second half for full-year outlook. There appear to be confidence issues in core compute and diversification initiatives. 
Customer foundry revenue was lower than expected in Q1, but product and technology pipeline remains strong. The company&#8217;s roadmap milestones are on track, with new products like Sierra Forest and Granite Rapids ramping up. Overall, while 2Q guidance is muted, there is optimism for a gradual recovery in general compute demand but Intel &#8220;will be an underperformer relative to the group over the next 12-18 months,&#8221; Sur says.
Goldman Sachs: Intel&#8217;s 2Q24 revenue and non-GAAP EPS guidance were lower than expected, attributed to the delayed recovery in traditional server demand now expected in H2. This delay is due to Cloud and Enterprise customers prioritizing AI infrastructure spending. &#8220;AI prioritization continues to weigh on traditional server demand&#8221; said Hari.
Goldman Sachs remains &#8220;encouraged by Intel's progress in Accelerating Computing&#8221;, particularly with the launch of Gaudi3. However, it faces challenges in maintaining its share in the Data Center Compute market against competitors like Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Arm Holdings PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>).
Oppenheimer: &#8220;We remain on sidelines as turnaround efforts take root,&#8221; said Schafer. He attributed Intel&#8217;s weaker Q1 performance to weaker demand and the sunsetting of non-core and traditional packaging. 
Management sees Q1 as the bottom, expecting quarter-over-quarter growth throughout the year. PC and data center (DC) sales are expected to be flat in Q2, with DC leading in the second half due to the ramp of the Gaudi3 accelerator and cyclical recovery in other segments. 
DC is expected to be up about 25% this year. Despite optimism, Intel&#8217;s roadmap and technology leadership are concerns for Schafer. While constructive on the data center outlook, caution remains regarding PC unit growth.
Needham: Bolton&#8217;s Hold rating is due to Intel&#8217;s high valuation, declining revenue estimates, growing competition, and distant IFS revenue contributions, &#8220;all setting up for a more difficult road ahead&#8220;. 
Intel faces challenges in the data center market, said Bolton, with wallet share shifting to AI-compute and competition from new architectures like ARM-based CPUs and evolving ASICs. While losses in Desktop and Notebook share have slowed, positive PC trends are insufficient to support INTC&#8217;s CY24 PC unit TAM.
Wedbush: Intel Corp is &#8220;still a work in progress,&#8221; said Bryson. He notes that Intel&#8217;s guidance for >$500M in Habana sales in 2H&#8217;24 was below expectations, despite prior commentary suggesting a larger backlog and increased AI accelerator spending. 
While Sierra Forrest and Granite Rapids are on track for release, Bryson sees their impact on Intel&#8217;s share and revenues being modest. Additionally, Meteor Lake experienced increased demand in CQ1, with units expected to double in CQ2, but supply constraints are hindering Intel&#8217;s ability to meet this demand as it ramps up wafer level assembly.
Wedbush also thinks &#8220;the recent pessimism weighing on the stock is arguably overdone.&#8221; But, analysts &#8220;still aren&#8217;t comfortable yet in getting more constructive around Intel.&#8221;
BofA Securities: Arya noted &#8220;higher costs, lower growth, tough competition,&#8221; as three key attributes identifiable with Intel&#8217;s Q1 earnings report and future outlook.
Intel&#8217;s Q1 earnings met expectations, but Q2 guidance disappointed due to high costs. While Arya sees the company&#8217;s strong enterprise position and US manufacturing assets offering potential, limited AI exposure could hamper growth. Q2 sales missed targets amid weak macro demand. 
However, Intel anticipates a strong second half driven by cyclical improvements, AI PC growth, and positive enterprise trends. The company is focusing on the Gaudi3 ramp, CHIPS grants, and cost reductions to improve profitability. Challenges include losing server market share and competition in AI accelerators. Arya sees Intel&#8217;s future success depending on leveraging manufacturing synergies and managing competition from Taiwan Semiconductor Manufacturing Co Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>).
Mizuho Securities: &#8220;We remain positive on INTC given stable compute server share, Sierra Forest and Granite Rapids product ramps ahead, and valuation with low expectations,&#8221; said Rakesh.
According to Rakesh, Intel&#8217;s data-centric AI (DCAI) segment remains flat as the company plays catch-up with peers, with the Gaudi3 ramp in 2H expected to contribute but still at a small scale. 
Intel&#8217;s data center (DC) is estimated to grow by 4% y/y in 2024, compared to Nvidia&#8217;s consensus estimate of 102% y/y growth. 
Intel is ramping its foundry business, adding external customers and anticipating margins to trough in 2024 before a stronger ramp in 2025. Despite a disappointing June quarter guide, Rakesh believes new product ramps and stable server share, combined with low expectations, could limit downside as Intel trades at a lower P/S multiple compared to Advanced Micro Devices Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) and Nvidia.
Read Next: <a href="https://www.benzinga.com/news/earnings/earnings-beats/24/04/38467013/tech-stocks-rebound-as-magnificent-7-roar-on-strong-earnings-energy-giants-tumble-wh">Tech Stocks Rebound As Magnificent 7 Roar On Strong Earnings, Energy Giants Tumble: What&#8217;s Driving Markets Friday?</a>
Image: Shutterstock

Analyst Color

Earnings

Analyst Ratings

Tech

INTC

NVDA

Intel 'Still A Work In Progress' As 'Turnaround Efforts Take Root,' Analysts Say After Q1 Disappointment

Optimism's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">OP</a>) price has decreased 4.11% over the past 24 hours to $2.35. This is contrary to the coins performance over the past week where it has experienced an up-trend of 3.0%, moving from $2.28 to its current price.
The chart below compares the price movement and volatility for Optimism over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.
<img src="https://www.benzinga.com/files/images/story/2024/1714158155_0.png" alt="price_chart" />
The trading volume for the coin has decreased 22.0% over the past week, while the overall circulating supply of the coin has increased 0.25% to over 1.05 billion. This puts its current circulating supply at an estimated 24.34% of its max supply, which is 4.29 billion. The current market cap ranking for OP is #50 at $2.46 billion.
<img src="https://www.benzinga.com/files/images/story/2024/1714158155_1.png" alt="supply_and_vol" />
<a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Cryptocurrency Optimism Decreases More Than 4% Within 24 hours

The Graph's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">GRT</a>) price has decreased 4.14% over the past 24 hours to $0.26, continuing its downward trend over the past week of -0.0%, moving from $0.26 to its current price. 
The chart below compares the price movement and volatility for The Graph over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.
<img src="https://www.benzinga.com/files/images/story/2024/1714158145_0.png" alt="price_chart" />
The trading volume for the coin has fallen 35.0% over the past week which is opposite, directionally, with the overall circulating supply of the coin, which has increased 0.19%. This brings the circulating supply to 9.48 billion, which makes up an estimated 87.9% of its max supply of 10.79 billion. According to our data, the current market cap ranking for GRT is #49 at $2.46 billion.
<img src="https://www.benzinga.com/files/images/story/2024/1714158145_1.png" alt="supply_and_vol" />
<a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Golden Ratio Token - United States Dollar

$GRT

Cryptocurrency The Graph Down More Than 4% Within 24 hours

Over the past 24 hours, Maker's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/mkr/usd">MKR</a>) price has risen 3.07% to $2,944.05. This is contrary to its negative trend over the past week where it has experienced a 2.0% loss, moving from $2,958.16 to its current price. As it stands right now, the coin's all-time high is $6,292.31. 
The chart below compares the price movement and volatility for Maker over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.
<img src="https://www.benzinga.com/files/images/story/2024/1714158075_0.png" alt="price_chart" />
The trading volume for the coin has decreased 34.0% over the past week, while the overall circulating supply of the coin has decreased 0.1% to over 925 thousand. This puts its current circulating supply at an estimated 92.0% of its max supply, which is 1.01 million. The current market cap ranking for MKR is #47 at $2.72 billion.
<img src="https://www.benzinga.com/files/images/story/2024/1714158075_1.png" alt="supply_and_vol" />
<a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$MKR

Cryptocurrency Maker Rises More Than 3% In 24 hours

In the latest quarter, 5 analysts provided ratings for Newmont (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>), showcasing a mix of bullish and bearish perspectives.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Newmont, presenting an average target of $46.5, a high estimate of $56.00, and a low estimate of $40.00. A decline of 8.82% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2024/1714158068_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The analysis of recent analyst actions sheds light on the perception of Newmont by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Greg Barnes</td>
<td>TD Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$48.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Alexander Hacking</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$45.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Tanya Jakusconek</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$43.50</td>
<td>$50.00</td>
</tr>
<tr>
<td>Jackie Przybylowski</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$56.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Josh Wolfson</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$40.00</td>
<td>$45.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Newmont. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Newmont compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Newmont's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Newmont's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/NEM/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Newmont analyst ratings.</a>
<h2>About Newmont</h2>
Newmont is the world's largest gold miner. It bought Goldcorp in 2019, combined its Nevada mines in a joint venture with competitor Barrick later that year, and also purchased competitor Newcrest in November 2023. Its portfolio includes 17 wholly or majority owned mines and interests in two joint ventures in the Americas, Africa, Australia and Papua New Guinea. The company is expected to produce roughly 6.9 million ounces of gold in 2024. However, after buying Newcrest, Newmont is likely to sell a number of its higher cost, smaller mines accounting for 20% of forecast sales in 2024. Newmont also produces material amounts of copper, silver, zinc, and lead as byproducts. It had about two decades of gold reserves along with significant byproduct reserves at end December 2023.
<h3>A Deep Dive into Newmont's Financials</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Positive Revenue Trend: Examining Newmont's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 23.66% as of 31 December, 2023, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.
Net Margin: Newmont's net margin excels beyond industry benchmarks, reaching -79.81%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Newmont's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -13.13%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Newmont's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -6.75%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Newmont's debt-to-equity ratio surpasses industry norms, standing at 0.33. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Analyst Ratings: What Are They?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What 5 Analyst Ratings Have To Say About Newmont

In the latest quarter, 5 analysts provided ratings for Laboratory Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LH#NYSE">LH</a>), showcasing a mix of bullish and bearish perspectives.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $242.4, a high estimate of $260.00, and a low estimate of $213.00. Experiencing a 4.19% decline, the current average is now lower than the previous average price target of $253.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1714158054_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of Laboratory Corp among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ryan MacDonald</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$255.00</td>
<td>$270.00</td>
</tr>
<tr>
<td>Stephanie Davis</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$213.00</td>
<td>$234.00</td>
</tr>
<tr>
<td>Eric Coldwell</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$244.00</td>
<td>$255.00</td>
</tr>
<tr>
<td>Michael Cherny</td>
<td>Leerink Partners</td>
<td>Announces</td>
<td>Outperform</td>
<td>$260.00</td>
<td>-</td>
</tr>
<tr>
<td>Elizabeth Anderson</td>
<td>Evercore ISI Group</td>
<td>Announces</td>
<td>In-Line</td>
<td>$240.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Laboratory Corp. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Laboratory Corp compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Laboratory Corp's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Laboratory Corp's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/LH/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Laboratory Corp analyst ratings.</a>
<h2>Get to Know Laboratory Corp Better</h2>
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
<h3>Key Indicators: Laboratory Corp's Financial Health</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: Laboratory Corp's remarkable performance in 3 months is evident. As of 31 December, 2023, the company achieved an impressive revenue growth rate of 3.54%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -5.51%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Laboratory Corp's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -2.12% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Laboratory Corp's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -0.99%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Laboratory Corp's debt-to-equity ratio is below the industry average. With a ratio of 0.76, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>What Are Analyst Ratings?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Laboratory Corporation Of America Holdings

Analyst Ratings For Laboratory Corp

Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Compass Minerals Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMP#NYSE">CMP</a>) in the last three months.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $22.5, a high estimate of $26.00, and a low estimate of $20.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 13.46%. 
<img src="https://www.benzinga.com/files/images/story/2024/1714158045_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Compass Minerals Intl. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Chris Kapsch</td>
<td>Loop Capital</td>
<td>Lowers</td>
<td>Buy</td>
<td>$23.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Joel Jackson</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$20.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Chris Kapsch</td>
<td>Loop Capital</td>
<td>Lowers</td>
<td>Hold</td>
<td>$26.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$21.00</td>
<td>$24.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Compass Minerals Intl. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Compass Minerals Intl compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Compass Minerals Intl's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Capture valuable insights into Compass Minerals Intl's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CMP/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Compass Minerals Intl analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Discovering Compass Minerals Intl: A Closer Look</h2>
Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Canada, the us state of Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.
<h3>Compass Minerals Intl: A Financial Overview</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Negative Revenue Trend: Examining Compass Minerals Intl's financials over 3 months reveals challenges. As of 31 December, 2023, the company experienced a decline of approximately -3.04% in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.
Net Margin: Compass Minerals Intl's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -22.04% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Compass Minerals Intl's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -15.41%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Compass Minerals Intl's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -4.16%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.99, caution is advised due to increased financial risk.
<h2>Analyst Ratings: What Are They?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings For Compass Minerals Intl

Throughout the last three months, 9 analysts have evaluated Churchill Downs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHDN#NASDAQ">CHDN</a>), offering a diverse set of opinions from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $145.67, a high estimate of $153.00, and a low estimate of $137.00. This upward trend is evident, with the current average reflecting a 1.58% increase from the previous average price target of $143.40.
<img src="https://www.benzinga.com/files/images/story/2024/1714158037_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
A clear picture of Churchill Downs's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Barry Jonas</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$145.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Jeffrey Stantial</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$153.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Ben Chaiken</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Buy</td>
<td>$143.00</td>
<td>$142.00</td>
</tr>
<tr>
<td>Daniel Politzer</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$141.00</td>
<td>$137.00</td>
</tr>
<tr>
<td>Jordan Bender</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$150.00</td>
<td>-</td>
</tr>
<tr>
<td>Daniel Politzer</td>
<td>Wells Fargo</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$137.00</td>
<td>-</td>
</tr>
<tr>
<td>Ben Chaiken</td>
<td>Mizuho</td>
<td>Announces</td>
<td>Buy</td>
<td>$142.00</td>
<td>-</td>
</tr>
<tr>
<td>Jordan Bender</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$150.00</td>
<td>-</td>
</tr>
<tr>
<td>Jordan Bender</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$150.00</td>
<td>$148.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Churchill Downs. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Churchill Downs compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Churchill Downs's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Churchill Downs's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/CHDN/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Churchill Downs analyst ratings.</a>
<h2>Unveiling the Story Behind Churchill Downs</h2>
Churchill Downs Inc is a gaming entertainment, online wagering, and racing company. It operates through three business segments: Live and Historical Racing, TwinSpires, and Gaming. The Live and Historical Racing segment includes live and historical pari-mutuel racing. The TwinSpires segment includes the revenue and expenses for online horse racing and the online and retail sports betting and iGaming wagering business. The Gaming segment includes revenue and expenses for the casino properties and associated racetracks that support the casino license. The Gaming segment generates revenue and expenses from slot machines, table games, video lottery terminals, video poker, HRMs, ancillary food and beverage services, hotel services, commission on pari-mutuel wagering, and racing events.
<h3>Churchill Downs's Financial Performance</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: Churchill Downs's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2024, the company achieved a revenue growth rate of approximately 5.61%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: Churchill Downs's net margin excels beyond industry benchmarks, reaching 13.61%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Churchill Downs's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 9.35%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Churchill Downs's ROA stands out, surpassing industry averages. With an impressive ROA of 1.15%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 5.96, caution is advised due to increased financial risk.
<h2>Analyst Ratings: What Are They?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CHDN

A Glimpse Into The Expert Outlook On Churchill Downs Through 9 Analysts

Cintas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTAS#NASDAQ">CTAS</a>) has outperformed the market over the past 15 years by 12.05% on an annualized basis producing an average annual return of 24.22%. Currently, Cintas has a market capitalization of $67.50 billion. 
Buying $1000 In CTAS: If an investor had bought $1000 of CTAS stock 15 years ago, it would be worth $25,941.17 today based on a price of $665.25 for CTAS at the time of writing.
<h3>Cintas's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714158029_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CTAS

Here's How Much $1000 Invested In Cintas 15 Years Ago Would Be Worth Today

During the last three months, 7 analysts shared their evaluations of Steven Madden (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHOO#NASDAQ">SHOO</a>), revealing diverse outlooks from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $42.0, a high estimate of $45.00, and a low estimate of $38.00. This upward trend is evident, with the current average reflecting a 4.14% increase from the previous average price target of $40.33.
<img src="https://www.benzinga.com/files/images/story/2024/1714158027_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The perception of Steven Madden by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$44.00</td>
<td>$44.00</td>
</tr>
<tr>
<td>Paul Lejuez</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$43.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Sam Poser</td>
<td>Williams Trading</td>
<td>Announces</td>
<td>Hold</td>
<td>$44.00</td>
<td>-</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$39.00</td>
<td>-</td>
</tr>
<tr>
<td>Abbie Zvejnieks</td>
<td>Piper Sandler</td>
<td>Announces</td>
<td>Neutral</td>
<td>$45.00</td>
<td>-</td>
</tr>
<tr>
<td>Tom Nikic</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Neutral</td>
<td>$38.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Paul Lejuez</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Neutral</td>
<td>$41.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Steven Madden. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Steven Madden compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Steven Madden's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
To gain a panoramic view of Steven Madden's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/SHOO/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Steven Madden analyst ratings.</a>
<h2>About Steven Madden</h2>
Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its own stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.
<h3>Breaking Down Steven Madden's Financial Performance</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Over the 3 months period, Steven Madden showcased positive performance, achieving a revenue growth rate of 10.43% as of 31 December, 2023. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Steven Madden's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 6.9%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Steven Madden's ROE stands out, surpassing industry averages. With an impressive ROE of 4.31%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Steven Madden's ROA stands out, surpassing industry averages. With an impressive ROA of 2.72%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Steven Madden's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.17.
<h2>What Are Analyst Ratings?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SHOO

Analyst Ratings For Steven Madden

AGBA Group Holding's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGBA#NYSE">AGBA</a>) short percent of float has risen 200.0% since its last report. The company recently reported that it has 97 thousand shares sold short, which is 0.54% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>AGBA Group Holding Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714158027_0_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for AGBA Group Holding has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing AGBA Group Holding's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, AGBA Group Holding's peer group average for short interest as a percentage of float is 5.52%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

AGBA

(AGBA) - Analyzing AGBA Group Holding's Short Interest

Booking Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKNG#NASDAQ">BKNG</a>) has outperformed the market over the past 20 years by 20.1% on an annualized basis producing an average annual return of 27.96%. Currently, Booking Holdings has a market capitalization of $119.15 billion. 
Buying $1000 In BKNG: If an investor had bought $1000 of BKNG stock 20 years ago, it would be worth $141,578.21 today based on a price of $3502.48 for BKNG at the time of writing.
<h3>Booking Holdings's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714158023_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BKNG

Here's How Much $1000 Invested In Booking Holdings 20 Years Ago Would Be Worth Today

Biglari Holdings's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BH#NYSE">BH</a>) short percent of float has fallen 12.66% since its last report. The company recently reported that it has 6 thousand shares sold short, which is 0.69% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.09 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Biglari Holdings Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714158022_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Biglari Holdings has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Biglari Holdings's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Biglari Holdings's peer group average for short interest as a percentage of float is 10.48%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Biglari Holdings's Recent Short Interest

12 analysts have shared their evaluations of Southwest Airlines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Southwest Airlines, revealing an average target of $31.75, a high estimate of $42.00, and a low estimate of $25.00. This upward trend is evident, with the current average reflecting a 6.9% increase from the previous average price target of $29.70.
<img src="https://www.benzinga.com/files/images/story/2024/1714158019_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
A clear picture of Southwest Airlines's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Helane Becker</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Hold</td>
<td>$25.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Savanthi Syth</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$30.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Brandon Oglenski</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$26.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Christopher Stathoulopoulos</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$27.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Ravi Shanker</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$38.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Brandon Oglenski</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$30.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Atul Maheswari</td>
<td>UBS</td>
<td>Announces</td>
<td>Buy</td>
<td>$36.00</td>
<td>-</td>
</tr>
<tr>
<td>David Vernon</td>
<td>Bernstein</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$27.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Sheila Kahyaoglu</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$28.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>John Staszak</td>
<td>Argus Research</td>
<td>Announces</td>
<td>Buy</td>
<td>$40.00</td>
<td>-</td>
</tr>
<tr>
<td>Michael Linenberg</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$42.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>David Vernon</td>
<td>Bernstein</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$32.00</td>
<td>$26.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Southwest Airlines. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Southwest Airlines compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Southwest Airlines's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Southwest Airlines's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/LUV/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Southwest Airlines analyst ratings.</a>
<h2>All You Need to Know About Southwest Airlines</h2>
Southwest Airlines is the largest domestic air carrier in the United States by passengers boarded. Southwest operates over 700 aircraft in an all-Boeing 737 fleet. Despite offering some longer routes and a few perks for business travelers, the airline predominantly specializes in short-haul, leisure flights, using a point-to-point network. Southwest operates a low-cost carrier business model.
<h3>Key Indicators: Southwest Airlines's Financial Health</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: Southwest Airlines's remarkable performance in 3 months is evident. As of 31 December, 2023, the company achieved an impressive revenue growth rate of 10.55%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Southwest Airlines's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -3.41% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Southwest Airlines's ROE excels beyond industry benchmarks, reaching -2.16%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of -0.63%, the company showcases effective utilization of assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.87.
<h2>Analyst Ratings: Simplified</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Where Southwest Airlines Stands With Analysts

General Mills's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIS#NYSE">GIS</a>) short percent of float has risen 12.7% since its last report. The company recently reported that it has 15.52 million shares sold short, which is 2.75% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.59 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>General Mills Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714158016_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for General Mills has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing General Mills's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, General Mills's peer group average for short interest as a percentage of float is 4.10%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into General Mills's Recent Short Interest

Render's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">RNDR</a>) price has decreased 4.29% over the past 24 hours to $8.23. This is contrary to the coins performance over the past week where it has experienced an up-trend of 3.0%, moving from $8.01 to its current price.
The chart below compares the price movement and volatility for Render over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.
<img src="https://www.benzinga.com/files/images/story/2024/1714158006_0.png" alt="price_chart" />
The trading volume for the coin has tumbled 47.0% over the past week while the circulating supply of the coin has risen 0.67%. This brings the circulating supply to 386.97 million, which makes up an estimated 72.73% of its max supply of 532.07 million. According to our data, the current market cap ranking for RNDR is #36 at $3.18 billion.
<img src="https://www.benzinga.com/files/images/story/2024/1714158006_1.png" alt="supply_and_vol" />
<a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$RNDR

Cryptocurrency Render Decreases More Than 4% Within 24 hours

Sam Adams maker Boston Beer Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) isn&#8217;t seeing its cannabis-infused beverage segment tap revenue <a href="https://www.benzinga.com/topic/beer">from its flagship lager</a>. 
What Happened: The company disclosed its financial results for the first quarter, which ended on March 30. Its performance exceeded analyst expectations, too. 
<ul>
<li>The company reported a net revenue of $426.1 million </li>
<li>That&#8217;s more than 3.1% higher than analyst estimates of $413.21 million.</li>
<li>Earnings per share (EPS) of $1.04 was above the analyst estimate for EPS of 9 cents.</li>
</ul>
Sam Adams likely owes some of its success to the backlash Anheuser-Busch Inbev (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUD#NYSE">BUD</a>) faced from conservative beer drinkers. The Bud Light parent company <a href="https://www.benzinga.com/news/earnings/24/02/37398043/why-bud-light-parent-ab-inbev-shares-are-taking-a-hit-today">saw sales plummet</a> on the heels of a promotional campaign with transgender influencer Dylan Mulvaney.
THC&#8217;s so-called cannibalization of alcohol doesn&#8217;t seem to resonate at Sam Adams, nor does it track at Tilray Brands Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>). The Florida-based cannabis company, which <a href="https://www.benzinga.com/markets/cannabis/23/10/35031971/tilray-completes-acquisition-of-8-beer-brands-from-bud-light-parent-anheuser-busch">purchased craft beer brands </a>from AB Inbev, <a href="https://news.bloomberglaw.com/cannabis/craft-beer-is-saving-tilray-from-cannabis-vegetable-woes-1">saw</a> alcohol revenue spike 117% to $47 million.
See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37893077/3-beer-stocks-what-this-analyst-thinks-is-brewing">3 Beer Stocks — What This Analyst Thinks Is Brewing</a>
Why It Matters: Even before Boston Beer first <a href="https://www.bostonbeer.com/news/2021/05/the-boston-beer-company-to-begin-research-and-development-of-non-alcoholic-cannabis-beverages" target="_blank" rel="noreferrer noopener">entered</a> the cannabis beverage market, industry analysts (i.e., Deloitte) <a href="https://www2.deloitte.com/content/dam/Deloitte/ca/Documents/c-and-ip/ca-en-consumer-nurturing-new-growth-en-aoda-may31.pdf">predicted</a> that alcohol and tobacco companies would utilize M&amp;A or establish new product segments &#8220;to avoid losing market share to competing cannabis products.&#8221;
But, as it turns out, Boston Beer&#8217;s customers are still enjoying Sam Adams in addition to new THC-infused items <a href="https://www.benzinga.com/markets/cannabis/22/05/27344695/the-boston-beer-company-introduces-teapot-a-new-line-of-cannabis-infused-iced-teas" target="_blank" rel="noreferrer noopener">such as</a> Teapot.
Teapot, the 40-year-old company boasts, is Canada&#8217;s premier cannabis tea brand. The company did not disclose THC beverage sales numbers in its most recent financial <a href="https://investors.bostonbeer.com/news-releases/news-release-details/boston-beer-reports-first-quarter-financial-results-1">report</a>. 
"We saw a unique opportunity as consumer relationships with alcohol evolve, especially in a post-COVID world, where cannabis acceptance is on the rise. This convergence of trends led us to create <a href="https://www.benzinga.com/topic/cannabis-beverages" target="_blank" rel="noreferrer noopener">cannabis-infused beverages</a>," Paul Weaver, head of cannabis at Boston Beer, told Benzinga last year.
Teapot is not listed among Boston Beer&#8217;s so-called &#8220;core brands&#8221; (Sam Adams, Angry Orchard Hard Cider, Dogfish Head, Truly Hard Seltzer and Twisted Tea). 
Boston Beer also backs Uncle Arnie&#8217;s, a <a href="https://www.benzinga.com/markets/cannabis/23/06/32829540/thc-beverage-uncle-arnies-raises-capital-with-investments-from-samuel-adams-founders">cannabis-infused beverage startup</a>. 
Other beer giants aren&#8217;t bullish on the THC drink segment. Molson Coors Beverages Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>), for example, exited a cannabis-related joint venture <a href="https://www.benzinga.com/markets/cannabis/22/11/29784310/molson-coors-says-farewell-to-cannabis-and-its-partnership-with-hexo-heres-why">HEXO Corp. in 2022</a>. 
Now Read: <a href="https://www.benzinga.com/markets/cannabis/23/08/34125331/boston-beer-exec-wants-to-turn-time-tested-liquor-logic-into-cannabis-retail-gold">Boston Beer Exec Wants To Turn Time-Tested Liquor Logic Into Cannabis Retail Gold</a>
Image: Shutterstock

Cannabis

TLRY

Sam Adams Says Hold My Beer — And You Are: Sales Numbers Dispute Cannabis Cannibalization Narrative

Apollo, KKR, Stonepeak Consider Investment In Intel Chip Joint Venture

WIIM

RIVN

Rivian shares are trading higher after the company announced plans to make its fast-charging network available to all EVs by late 2024.

PARA

PARAA

Matrix Asset Advisors Say Majority Of Paramount Shareholders Are Against Paramount/Skydance Deal ,feel Deal Is Not In Shareholders' Interests

GE HealthCare: Great Quarter, Upside Remains

GE Healthcare: Unveiling Red Flags In Its Growth Story

Siemens Healthineers: A High Quality Option In The Healthcare Industry

ResMed product recall classified as most serious by FDA

ResMed product recall classified as most serious by FDA (update)

Koninklijke Philips: Still On The Cautious Line

Koninklijke Philips N.V. (PHG) Q4 2023 Earnings Call Transcript

ResMed positive as Philips halts sales of sleep therapy devices

Koninklijke Philips N.V. 2023 Q4 - Results - Earnings Call Presentation

Artisan International Value Fund Q1 2024 Commentary

ACGL

ACGLN

BABA

BABAF

CAJFF

CAJPY

GEHC

INSP

MSCI

NHNCF

SAFRF

SAFRY

SEMHF

SIEGY

SMMNY

VALE

Koninklijke Philips

FDA Gives 'Most Severe' Class I Label To Philips' Recall Of Faulty Ventilators, Sleep Apnea Machines

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Koninklijke Philips Stock (OTC:RYLPF)

Friday, July 23, 2021

Monday, June 14, 2021

Tuesday, July 23, 2019